| Nome |
# |
|
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo, file e39773b1-6632-35a3-e053-3a05fe0aac26
|
3.724
|
|
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis, file e39773b2-1c08-35a3-e053-3a05fe0aac26
|
2.176
|
|
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE, file e39773b2-2fc0-35a3-e053-3a05fe0aac26
|
908
|
|
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model, file e39773b2-1c52-35a3-e053-3a05fe0aac26
|
428
|
|
Granulocytes in actively induced Lewis rat EAE, file e39773b4-b98e-35a3-e053-3a05fe0aac26
|
426
|
|
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models, file e39773b2-1978-35a3-e053-3a05fe0aac26
|
339
|
|
MSCs effect on Dark Agouti rats affected by chronic EAE, file e39773b1-f4c1-35a3-e053-3a05fe0aac26
|
278
|
|
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis., file e39773b4-dab6-35a3-e053-3a05fe0aac26
|
220
|
|
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain, file e39773b2-0bd4-35a3-e053-3a05fe0aac26
|
168
|
|
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy, file e39773b2-1b32-35a3-e053-3a05fe0aac26
|
151
|
|
Current view in platinum drug mechanisms of peripheral neurotoxicity, file e39773b2-c7c1-35a3-e053-3a05fe0aac26
|
141
|
|
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics?, file e39773b2-1a13-35a3-e053-3a05fe0aac26
|
114
|
|
Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models, file e39773b8-0628-35a3-e053-3a05fe0aac26
|
98
|
|
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy, file e39773b8-c109-35a3-e053-3a05fe0aac26
|
97
|
|
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity, file e39773b6-d43d-35a3-e053-3a05fe0aac26
|
92
|
|
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats, file e39773b7-32a4-35a3-e053-3a05fe0aac26
|
92
|
|
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer, file e39773b7-0ea5-35a3-e053-3a05fe0aac26
|
90
|
|
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats, file e39773b2-164e-35a3-e053-3a05fe0aac26
|
87
|
|
Oxaliplatin induces pH acidification in dorsal root ganglia neurons, file e39773b7-0b54-35a3-e053-3a05fe0aac26
|
68
|
|
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats, file e39773b6-b52b-35a3-e053-3a05fe0aac26
|
66
|
|
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights, file e39773b6-b1ab-35a3-e053-3a05fe0aac26
|
64
|
|
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity, file e39773b6-b81b-35a3-e053-3a05fe0aac26
|
63
|
|
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity, file e39773b6-f6cc-35a3-e053-3a05fe0aac26
|
57
|
|
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED
PERIPHERAL NEUROPATHY, file f0470f39-c76f-4099-a822-b18862e0d9ab
|
56
|
|
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models, file e39773b2-167c-35a3-e053-3a05fe0aac26
|
55
|
|
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib, file e39773b2-1924-35a3-e053-3a05fe0aac26
|
53
|
|
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse, file e39773b2-1679-35a3-e053-3a05fe0aac26
|
52
|
|
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats, file e39773b2-145c-35a3-e053-3a05fe0aac26
|
51
|
|
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE, file e39773b7-0303-35a3-e053-3a05fe0aac26
|
51
|
|
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS, file e39773b2-196d-35a3-e053-3a05fe0aac26
|
44
|
|
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis, file e39773b2-1635-35a3-e053-3a05fe0aac26
|
41
|
|
Neurochemical characterization of bortezomib-induced peripheral neuropathy: expression of trpv1, cgrp and substance p in the rat drg and dorsal horn of spinal cord, file e39773b2-1b34-35a3-e053-3a05fe0aac26
|
40
|
|
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY, file e39773b2-1969-35a3-e053-3a05fe0aac26
|
39
|
|
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level, file e39773b2-13dd-35a3-e053-3a05fe0aac26
|
37
|
|
Imidazoline Receptor 2 is an Effective Target for Neuropathic Pain in a Murine Model of Bortezomib-Induced Peripheral Neuropathy, file e39773b2-1469-35a3-e053-3a05fe0aac26
|
37
|
|
null, file e39773b2-1a5b-35a3-e053-3a05fe0aac26
|
36
|
|
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS, file e39773b2-150a-35a3-e053-3a05fe0aac26
|
35
|
|
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models, file e39773b2-1956-35a3-e053-3a05fe0aac26
|
31
|
|
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy, file 63ca8f63-04b5-4e18-890b-d764f6f0c735
|
29
|
|
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain, file e39773b2-0be4-35a3-e053-3a05fe0aac26
|
28
|
|
null, file e39773b2-19fd-35a3-e053-3a05fe0aac26
|
26
|
|
Transient receptor potential vanilloid type 1 (TRPV1) and neuropeptides in the dorsal root ganglia and spinal cord in a rat model of Bortezomib-induced neuropathy, file e39773b2-1d69-35a3-e053-3a05fe0aac26
|
25
|
|
TUBULIN: A TARGET FOR SEVERAL ANTINEOPLASTIC DRUGS, file e39773b2-1424-35a3-e053-3a05fe0aac26
|
24
|
|
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE, file e39773b7-8f17-35a3-e053-3a05fe0aac26
|
24
|
|
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity, file a532b52d-9098-4669-ae4a-87444f532efe
|
20
|
|
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?, file 9483fb75-5736-4668-a72b-e6605abc85bc
|
18
|
|
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing, file 45486cc9-830d-42fc-bc60-c746eea64a6c
|
13
|
|
CIPN and its mechanism of development, file dd095e2a-73b7-4183-bd58-19cae50cedab
|
11
|
|
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function, file 461f713c-5f84-4333-bccf-17625c910bc1
|
10
|
|
Oxaliplatin induces pH acidification in dorsal root ganglia neurons, file e39773b7-94fc-35a3-e053-3a05fe0aac26
|
10
|
|
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS, file e39773b3-2844-35a3-e053-3a05fe0aac26
|
9
|
|
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats, file cea6553f-71dd-4608-96fa-1c22547da1fa
|
8
|
|
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL, file e39773b2-1a10-35a3-e053-3a05fe0aac26
|
8
|
|
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity, file e42c0ca3-73cd-42c6-86c5-38199894ff13
|
8
|
|
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS, file e39773b2-1977-35a3-e053-3a05fe0aac26
|
7
|
|
Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin, file d1f84975-1486-4704-8b12-8f43dc0a553d
|
6
|
|
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY, file e39773b2-1420-35a3-e053-3a05fe0aac26
|
6
|
|
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats, file e39773b7-8c00-35a3-e053-3a05fe0aac26
|
6
|
|
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model., file e39773b2-1a9d-35a3-e053-3a05fe0aac26
|
5
|
|
Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models, file 3de7dbb9-1899-455e-b79f-213f0b473933
|
4
|
|
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats, file e39773b2-2f84-35a3-e053-3a05fe0aac26
|
3
|
|
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection, file e39773b8-59ec-35a3-e053-3a05fe0aac26
|
3
|
|
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration, file 0917be4b-4e1c-49de-b341-73267fca187f
|
2
|
|
Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models, file ecae5e97-c564-495a-a421-185f9d8ad1c7
|
2
|
|
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models, file e39773b2-1803-35a3-e053-3a05fe0aac26
|
1
|
|
The part of the Complete Freund’s Adjuvant in actively induced Experimental Autoimmune Encephalomyelitis in Lewis rat., file e39773b2-2580-35a3-e053-3a05fe0aac26
|
1
|
|
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF DIFFERENT MOLECULAR MECHANISMS, file e39773b5-e1b1-35a3-e053-3a05fe0aac26
|
1
|
|
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy, file e39773b8-47f0-35a3-e053-3a05fe0aac26
|
1
|
|
Artificial apolipoprotein corona enables nanoparticle brain targeting, file e39773b8-53df-35a3-e053-3a05fe0aac26
|
1
|
| Totale |
10.925 |
